CeriBell (CBLL) Stock: Buy, Sell, or Hold?
CBLL - CeriBell, Inc. Common Stock
$23.88
0.27 (1.12%)
â˛
5d:
+0.78%
30d:
-3.77%
90d:
+20.64%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When CBLL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CBLL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CBLL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CBLL is currently trading at $23.88, which is considered slightly low relative to its 30-day fair value range of $23.69 to $24.66.
Technical Outlook: Technically, CBLL is in a strong uptrend. The price is currently testing key support at $23.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CBLL scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.00 (+18.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CBLL is in a strong uptrend. The price is currently testing key support at $23.19. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CBLL scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.00 (+18.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$23.69 -
$24.66
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($28.00)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.69 -
$24.66
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$23.19
Resistance Level
$25.31
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.64
Wall Street Target
$28.00
(+18.6%)
Revenue Growth (YoY)
32.5%
Profit Margin
-64.7%
Share & Embed Analysis
Last updated: October 02, 2026 11:10 AM ET
Data refreshes hourly during market hours. Next update: 12:10 PM
Data refreshes hourly during market hours. Next update: 12:10 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CBLL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Xingjuan Chao
SELL
39000 shares
2026-04-06
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 64 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 44 HOLD |
